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Acute rheumatic fever (ARF) continues to be a 
significant cause of acquired heart disease in resource-
limited settings.[1-3] If recurrent or associated with 
moderate to severe carditis during the initial episode, 
ARF may lead to rheumatic heart disease (RHD), 
resulting in progressive and permanent cardiac valve damage.[4] 
Primary episodes of ARF occur mainly in children aged 5 - 15 
years and are rare in children under 5 years of age.[5] Predisposing 
factors for ARF and RHD include poor socioeconomic conditions, 
undernutrition, overcrowding, close person-to-person contact and 
poorly developed healthcare facilities.[1,6]
Owing to improved standards of living, medical care and use 
of antimicrobial agents, ARF and RHD are no longer a significant 
problem in most developed countries except for certain ethnic groups 
such as the indigenous populations of Australia and New Zealand.[7,8]
Estimates from 2005 showed that most of the 15 - 19 million 
people affected by RHD worldwide were living in developing 
countries, and an estimated 233 000 people were dying annually 
from RHD.[7] Recent estimates based on community-based 
echocardiographic screening suggest that the burden could be 
much higher,[9] with estimates from Mozambique showing a 
prevalence of RHD of 30.4/1 000 among schoolchildren.[2] This 
is higher than the estimated RHD prevalence of 5.7/1  000 from 
earlier studies for sub-Saharan Africa (SSA).[7] In a recent review 
by Zühlke et al.,[10] hospital-based estimates showed that RHD 
remains a significant cause of morbidity in Africa, with 6.6 - 34% 
of patients hospitalised with cardiovascular diseases or seen in 
echocardiographic clinics having RHD. Complications of ARF 
and RHD include valve insufficiency, heart failure, infective 
endocarditis and death.[11] Surgical repair or replacement of 
damaged heart valves remains largely unavailable in the developing 
world,[12] and non-surgical management of ARF and RHD with 
palliative treatment of heart failure and secondary prophylaxis to 
slow progression continue to be the primary forms of treatment 
available in these resource-limited settings.[1,3,12]
SSA has historically been estimated to be the region most affected 
by RHD,[7] prompting the Pan-African Society of Cardiology to 
initiate a programme to raise Awareness of the disease, encourage 
Surveillance of the disease pattern, Advocate for resources and 
promote Prevention programmes (ASAP), aiming for the control 
and elimination of ARF/RHD in the region.[13] While sites with 
register-based RHD control programmes have been set up in some 
African countries,[14,15] little is known about RHD in Zimbabwe and 
the country has largely lagged behind in implementing these control 
programmes. The real burden of ARF and RHD, the clinical and 
demographic characteristics of these patients, and the adequacy 
of treatment practices have not been documented systematically. 
The objectives of the present study were therefore to document 
cases of ARF and RHD among children presenting at referral 
hospitals in Harare, to determine their clinical and echocardiographic 
characteristics, and to identify opportunities for improving care of 
these patients in Zimbabwe.
Background. Acute rheumatic fever (ARF) and rheumatic heart disease (RHD) remain significant causes of morbidity and mortality in 
resource-limited settings. In Zimbabwe ARF/RHD characteristics have not been systematically documented.
Objectives. To document cases of ARF/RHD among children presenting at referral hospitals in Harare, Zimbabwe, determine their clinical 
and echocardiographic characteristics, and identify opportunities for improving care.
Methods. A cross-sectional survey was carried out in which consecutive children aged 1 - 12 years presenting with ARF/RHD according to 
the 2002/3 World Health Organization modified Jones criteria were enrolled.
Results. Out of 2 601 admissions and 1 026 outpatient visits over 10 months, 50 children were recruited, including 31 inpatients with 
ARF/RHD and 19 outpatients with chronic RHD. Among inpatients, 9 had ARF only, 7 recurrent ARF with RHD, and 15 RHD only. The 
commonest valve lesions were mitral regurgitation (26/31) and aortic regurgitation (11/31). The commonest reason for admission was 
cardiac failure (22/31). The proportion of ARF/RHD cases among inpatients aged 1 - 12 years was 11.9/1 000. Of the 22 with RHD, 14 
(63.6%) presented de novo and 1 had bacterial endocarditis. Among the outpatients, 15 had cardiac failure while echocardiographic findings 
included mitral regurgitation (18/19) and aortic regurgitation (5/19). At presentation, 18/26 known cases were on oral penicillin prophylaxis 
and 7 on injectable penicillin. Of those on secondary prophylaxis, 68.0% reported taking it regularly.
Conclusion. ARF/RHD remains a major problem and cause of hospital admissions in Harare, Zimbabwe. Children often present late with 
established RHD and cardiac failure. With the majority on oral penicillin, secondary prophylaxis was suboptimal in a resource-limited 
setting unable to offer valve replacement surgery.
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Methods
Permission to conduct the study was obtained 
from the Harare Central Hospital Medical 
Ethics Board and the Joint Research Ethics 
Council of the College of Health Sciences, 
University of Zimbabwe, and Parirenyatwa 
Central Hospital. Written informed consent 
from caregivers and assent from children 
aged 8 - 12 years were obtained. A descriptive, 
cross-sectional survey of children 1 - 12 
years of age seen at Harare and Parirenyatwa 
Central hospitals in Harare, Zimbabwe, was 
carried out between July 2012 and May 
2013. At both hospitals, patients seen in the 
paediatric units are aged ≤12 years, while 
those younger than 1 year were excluded 
from the study because of the rarity of group 
A streptococcal (GAS) sore throat and ARF 
below this age.[1,5] The children treated at 
these two institutions are either referred from 
the surrounding city, district and provincial 
health facilities or admitted through 
the emergency department. Children 
hospitalised in the paediatric medical wards 
in both hospitals or seen in the paediatric 
cardiac clinic based at Parirenyatwa Hospital 
were screened for possible enrolment in the 
study. They were enrolled if they showed 
evidence of congestive cardiac failure (CCF), 
cardiac murmur, arthritis or chorea and 
if they satisfied the 2002/3 World Health 
Organization modified Jones criteria for 
ARF and RHD.[1] Children were considered 
to have ARF recurrence in the presence 
of a documented prior history of ARF or 
established RHD.[16] Hospitalised patients 
were followed up to discharge or death 
during the initial presentation.
The data collected for each patient 
included demographics, clinical features, 
history of sore throat in the preceding 4 
weeks, echocardiographic features, and 
select laboratory results as ordered by the 
attending paediatrician (C-reactive protein 
(CRP), erythrocyte sedimentation rate 
(ESR), leucocyte count and anti-streptolysin 
O titre (ASOT)). Reference laboratory values 
specific to the Zimbabwean population have 
not been established, so standard laboratory 
reference values were used. A 12-lead resting 
electrocardiogram (ECG) and rhythm strip 
were used to assess for the presence of 
arrhythmias and a prolonged PR interval 
according to age-appropriate references.[17] 
Where available, the patient’s most recent 
chest X-ray was reviewed and the presence 
of cardiomegaly noted.
A complete two-dimensional paediatric 
echocardiogram was performed in all the 
hospitalised eligible patients and in 18 of the 
outpatients with Doppler and colour flow 
mapping according to American Society of 
Echocardiography guidelines.[18] Pulmonary 
hypertension was defined as an estimated 
right ventricular systolic pressure >35 mmHg 
by continuous-wave Doppler.[17] All images 
were recorded and subsequently reviewed 
by an independent paediatric cardiologist. 
Echocardiography was performed using a 
Sonosite M-turbo USS SN NG020N portable 
echocardiography machine, with a P21x/5-1 
MHz transducer (Sonosite Inc., USA).
Statistical analysis
Data were collected, verified and checked 
for completeness and missing data retrieved 
from admission and laboratory records. This 
was then entered into a REDCap (Research 
Electronic Data Capture) database hosted at 
the University of Zimbabwe.[19] The data were 
first exported to Microsoft Excel (Microsoft 
Corporation, USA) for quality assessment, 
then imported into Stata, version 10.1 
(StataCorp, USA) for descriptive analysis. 
Descriptive statistics between patient groups 
were compared using the χ2 test. A p-value of 
<0.05 was considered significant.
Results
Patient screening and enrolment are 
summarised in Fig. 1. A total of 2 601 
children aged 1 - 12 years were admitted 
to the paediatric medical units over the 
study period. One hundred and two children 
(3.9%) presented with a cardiac murmur, 
CCF, arthritis or chorea. Of the 2 601 children 
hospitalised during the study period, 31 had 
ARF and/or RHD, giving an overall case rate 
of 11.9/1 000 hospitalised children. Only 
two of the children were aged <5 years, 
and both had ARF only. Chronic RHD was 
present in 22 of 85 children hospitalised with 
cardiovascular-related conditions, giving a 
case rate of RHD among such children of 
25.9%. There were a total of 1 026 outpatient 
visits by children aged 1 - 12 years, from 
which 19 children were seen with chronic 
RHD.
Demographic characteristics
Of the 50 children seen with ARF and/or 
RHD, 32 (64.0%) were female. The median 
age was 9.5 years (interquartile range 7.5 - 
10.5 years). All of the children were black 
Africans. A reported family history of RHD 
was present in 3/50 children (6.0%). Most of 
the children seen were from either a rural 
or farming area of residence (54.0%) or an 
urban high-density area (30.0%).
Clinical presentation
Table 1 summarises the clinical features of 
enrolled subjects. Among the 16 children 
with ARF, 9 (56.3%) presented with an initial 
episode of ARF, while ARF recurrence with 
established RHD was present in 7 children 
(43.8%), of whom 2 had a documented 
history of prior ARF; both had established 
RHD.
Overall, 15/41 (36.6%) of children with 
chronic RHD presented de novo with no 
prior documented history of ARF or RHD. 
The proportion of patients presenting with 
RHD in the absence of prior documented 
ARF was higher among hospitalised children 
(14/22, 63.6%). The most common clinical 
feature at hospitalisation was carditis, which 
was present in 25/31 (80.6%) children, of 
whom 22/25 (88.0%) had CCF. Acute cardiac 





31 children had ARF or RHD 19 children had chronic RHD
Total children with ARF and/or RHD n=50
102 children had carditis
and/or arthritis and/or chorea
2 499 did not meet inclusion
criteria








palsy n=1, consent denied
n=1
Fig. 1. Flow diagram of patient enrolment. 
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hospitalised with RHD and in 2/9 (22.2%) children hospitalised with 
ARF only.
Among the 16 children with ARF, one major Jones criterion was 
present in 11 (68.8%) and two major criteria in 5 (31.3%), specifically 
carditis plus chorea in 3, carditis plus arthritis in 1 and carditis plus 
subcutaneous nodules in 1. No child had more than two major Jones 
criteria. Carditis was the most common major Jones criterion, present in 
10 children (62.5%), followed by chorea in 5 (31.3%) and arthritis also 
in 5 (31.3%). Subcutaneous nodules were uncommon and seen in only 1 
child (6.3%), while none had erythema marginatum. The most common 
minor Jones criteria were fever in 11 (68.8%), elevated acute-phase 
reactants in 13 (81.3%) (being leucocytosis in 7 (43.8%)), elevated ESR 
in 8 (50.0%) and elevated CRP in 7 (43.8%). Polyarthralgia was present 
in 6 children (37.5%) and first-degree heart block in 2 (12.5%). Elevated 
ASOT was present in 12 children (75.0%) with ARF, while there was a 
history of sore throat within the preceding 4 weeks in 9 (56.3%).
Comorbid illnesses were present in 12/31 hospitalised children 
(38.7%), including pneumonia in 5, tonsillitis in 2, ascites in 2, 
severe anaemia in 1, post-streptococcal glomerulonephritis in 1 
and cerebrovascular accident in 1. Among the 19 children seen as 
outpatients, 15 (78.9%) had chronic cardiac failure and 18 (94.7%) a 
cardiac murmur.
Echocardiographic findings
Among the hospitalised children, the most common valve lesion was 
mitral regurgitation (MR), present in 26/31 (83.9%) and in 11/16 
(68.8%) of the children with ARF (Table 2). Aortic regurgitation 
(AR) and mitral regurgitation were present concurrently in 11/22 
children (50.0%) with ARF and/or RHD. Mitral stenosis (MS) 
was present in 2 patients aged 9 and 12 years, and no patient had 
aortic stenosis or isolated AR. Left ventricular systolic dysfunction 
was present in 14/31 hospitalised children (45.2%) and pulmonary 
hypertension in 13 (41.9%). Among outpatients, MR was present 
in all of the 18 children (100%) who underwent echocardiography 
at presentation, AR in 5 (27.8%) and pulmonary hypertension in 4 
(22.2%).
Table 1. Description of the children seen with ARF and/or RHD, including clinical features











Prior history of RHD
Prior history 26 (52.0) - 2 (28.6) 6 (40.0) 18 (94.7)
De novo RHD 15 (30.0) - 5 (71.4) 9 (60.0) 1 (5.3)
Clinical features
Arthritis - 4 (44.4) 1 (14.3) 1 (6.7) -
Carditis - 4 (44.4) 6 (85.7) 15 (100.0) 19 (100.0)
Cardiomegaly on chest X-ray, when available - 1/6 6/6 11/11 6/6
Chorea - 3 (33.3) 2 (28.6) - -
Subcutaneous nodules - - 1 (14.3) - -
Fever - 6 (66.7) 5 (71.4) 4 (26.7) -
Polyarthralgia - 3 (33.3) 3 (42.9) 3 (20.0) -
 Elevated acute phase reactants - 8 (88.9) 5 (71.4) 5 (33.3) -
Elevated ESR - 4 (44.4) 4 (57.1) 2 (13.3) -
Elevated CRP - 4 (44.4) 3 (42.9) 2 (13.3) -
Leucocytosis - 3 (33.3) 4 (57.1) 4 (26.7) -
Elevated ASOT - 7 (77.8) 5 (71.4) 1 (6.7) -
 A recent history of sore throat - 5 (55.6) 4 (57.1) 5 (33.3) -
 Prolonged PR interval for age - 2 (22.2) - 3 (20.0) -
 Clinical pulmonary hypertension 25 (50.0%) - 2 (28.6) 14 (93.3) 9 (47.4)
Table 2. Description of the echocardiographic features in children presenting with ARF/RHD
All (N=49)
n (%)









MR 44 (89.8) 4 (44.4) 7 (100) 15 (100) 18 (100)
MR + MS 2 (4.1) 0 (0.0) 1 (14.3) 1 (6.7) -
MR + AR 16 (32.7) 0 (0.0) 2 (28.6) 9 (60.0) 5 (27.8)
Left ventricular systolic dysfunction 21 (42.9) 3 (33.3) 4 (57.1) 7 (46.7) 7 (38.9)
Pulmonary hypertension 17 (34.7) 1 (11.1) 1 (14.3) 11 (73.3%) 4 (22.2)
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Complications of ARF/RHD
Congestive cardiac failure (22/31, 71.0%) and pulmonary hyper-
tension (13/31, 41.9%) on echocardiography were the commonest 
complications of ARF/RHD in hospitalised children. On 12-lead 
ECG, no patient was found to have cardiac arrhythmias. One 
hospitalised child had suffered a cerebrovascular accident secondary 
to infective endocarditis. Two (6.5%) of the 31 hospitalised children 
died, one from severe heart failure and the other from infective 
endocarditis.
Treatment and secondary prophylaxis
Medical therapy for complications was the main form of treat-
ment available for children with ARF/RHD, with no open heart 
surgical facilities available locally. One child who was hospitalised 
for evaluation had undergone mitral valve replacement in another 
country.
Of the 26 patients known to have ARF/RHD, 25 (96.2%) were 
on secondary penicillin prophylaxis at presentation (Table 3). The 
majority (18/25, 72.0%) of the children were on oral penicillin, 
while 7/25 (28.0%) were on long-acting intramuscular penicillin 
prophylaxis. One child, a known case of ARF who was not on 
antibiotic prophylaxis at presentation, had been hospitalised with 
recurrent ARF and RHD. Almost a third (8/25, 32.0%) of the known 
cases self-reported forgetting to take secondary penicillin prophylaxis 
regularly. There was no significant association between the type of 
penicillin prophylaxis and a reported history of missing antibiotic 
prophylaxis (p=0.15).
Discussion 
This study showed that ARF remains common and is a major cause 
of hospitalisation among children presenting to referral hospitals in 
Harare. A number of children presented de novo with established 
RHD and cardiac failure, and secondary antibiotic prophylaxis for 
children with ARF/RHD was suboptimal. It was significant that 
63.6% of the children who were hospitalised with established RHD 
presented without a prior history of ARF, showing that even patients 
<12 years of age tended to present late. This was a higher proportion 
compared with the 8.6% of patients with de novo presentation of 
RHD seen in the Heart of Soweto study[20] and the 38% in a Fijian 
study,[16] although those studies included older patients who may have 
had different healthcare-seeking behaviour compared with younger 
children. However, in a longitudinal study in Australia, it was noted 
that the risk of developing RHD following initial diagnosis of ARF 
decreased with older age and time from diagnosis.[21]
The overall case rate of ARF/RHD among hospitalised children 
aged 1 - 12 years was high at 11.9/1 000, with 25.9% of the 
children hospitalised with cardiovascular-related conditions having 
established RHD. In a recent review by Zühlke et al.,[10] 6.6 - 34% of 
children hospitalised or seen in echocardiographic clinics in Africa 
had RHD.
While no significant association between gender and ARF has 
been described in the literature, in this study there were more females 
than males with ARF/RHD, with 64.0% being female. A positive 
family history of RHD was found in 6.0% of the patients in this small 
study, which is consistent with previous work that showed a genetic 
association, with a positive family history being present in 2 - 14% of 
patients with ARF.[22-25]
Clinical and echocardiographic features among children with ARF 
were comparable to findings from similar settings, with carditis being 
the commonest major Jones criterion.[24,26] The rate of migratory 
polyarthritis in this cohort was relatively low at 31.3%. A recent 
worldwide review described a higher frequency of arthritis, almost 
equal in frequency to carditis (59.3% v. 59.5%).[25] The frequency of 
chorea (31.3%) was similar to findings from other hospital-based 
studies in low-resource settings, where this ranged from 18.8% in 
India[22] to 27.5% in Brazil.[24] Subcutaneous nodules were rare (6.3%), 
and no child presented with erythema marginatum. In studies from 
other low-resource settings these major criteria ranged in frequency 
from 0% to 5.9%,[22-25] while in Montreal, Canada, a developed 
country with a predominantly Caucasian population, Carceller et 
al.[27] found a higher proportion with erythema marginatum of 23.5%.
Among the minor Jones criteria, the frequency of fever (68.8%), 
and polyarthralgia (37.5%) was not significantly different from 
previous findings by other workers.[16,24-26] Elevated CRP was present 
in 43.8%, comparable to 42% seen in Sydney, Australia.[26] In contrast, 
the frequency of elevated ESR (50.0%) was lower than 94% observed 
in Saudi Arabia.[28] One child in the present study was noted to 
have concurrent ARF and post-streptococcal glomerulonephritis, an 
unusual occurrence that is thought to be due to some GAS strains 
being both nephritogenic and rheumatogenic.[29]
Among the children with ARF, mitral regurgitation was the 
predominant valve lesion on echocardiography. Mitral valve 
regurgitation has been found to be the most frequent cardiac lesion 
in patients with ARF with documented frequencies varying from 
21.6% in India[22] to 77% in Australia,[26] and has also been associated 
with recurrent episodes of ARF.
All 15 children hospitalised with RHD alone had chronic CCF, 
a very high proportion compared with Fiji, where CCF was the 
reason for admission in 51% of children.[16] Only one child (6.7%) 
was admitted with infective endocarditis in the present study, which 
is lower than findings reported in the Fiji (10.6%),[16] Canadian 
(16.3%)[27] and Indian (36.5%)[22] studies. These differences may be 
explained in part by age; in the present study the oldest patient was 
12 years old, whereas the other investigators included older patients. 
However, despite the relatively young age of children in the present 
study there was still a high frequency of CCF, which may be due to 
late presentation with severe forms of the disease.
MR was also the predominant valve lesion in children with RHD 
only, being present in all of the children, followed by AR in 42.4%. 
This is comparable to previous observations in Fiji, where 91% of 
the patients had mitral valve involvement,[16] but was higher than in 
India, where MR was present in 39.5% and AR in 3.9%,[22] probably 
owing to late presentation in this setting with more advanced disease. 
MS was rare, as expected given the age limit of 12 years in the patients 
seen. No arrhythmias were documented, which is not surprising 
given the young population that was studied in this series.
Treatment of patients with complications of RHD was primarily 
supportive, with no facilities for surgical repair. Only one patient 
had mitral valve replacement done while her family was living in 
another country. Open-heart surgery is currently not available in 
Zimbabwe.
Optimising secondary antibiotic prophylaxis is necessary to 
improve ARF and RHD outcomes, especially in settings where 
surgical options are not available. In this study secondary antibiotic 
prophylaxis was mainly with oral penicillin, which is suboptimal, 
Table 3. Secondary prophylaxis
n/N (%)
Penicillin prophylaxis at presentation 25/26 (96.2)
Oral penicillin 18/25 (72.0)
Injectable penicillin 7/25 (28.0)
Reported history of missing antibiotic prophylaxis 8/25 (32.0)
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consistent with other studies.[22,30] Secondary prophylaxis has 
been shown to be effective only when there is a high level of 
compliance, with an increased risk of recurrence and more severe 
RHD among patients defaulting treatment.[31-33] While the majority 
(96.2%) of children previously diagnosed with ARF/RHD were on 
penicillin prophylaxis at presentation, only 68.0% reported taking 
the prophylaxis regularly. This lack of adherence to penicillin 
prophylaxis has also been reported in a study from 16 developing 
countries between 1986 and 1990, when adherence was reported to 
be 63.2%.[30] Although 68.0% were said to be adherent to secondary 
prophylaxis, 76.0% of patients in this series were on oral penicillin. 
Several previous studies have shown parenteral penicillin to be more 
efficacious than oral penicillin.[34-36]
Study limitations
This was a hospital-based study with the usual limitations. The wards 
were visited daily to screen all hospitalised children. Hospitalised 
children tend to reflect only the severe cases, and minor cases may 
be missed. Community rates of ARF and RHD cannot be directly 
inferred from this hospital-based data. Other study variables such as 
regular use of penicillin prophylaxis were based on history only and 
could have been affected by recall bias. The relatively small sample 
size also reduced the statistical power of the study.
Conclusions
ARF remains a significant problem and cause of hospital admissions 
among children presenting at referral hospitals in Harare, Zimbabwe, 
many of whom present with de novo advanced RHD. Clinical and 
echocardiographic features of patients with ARF and RHD in 
Zimbabwe were comparable to findings from other studies done 
in resource-limited settings. Adherence to secondary penicillin 
prophylaxis among patients with ARF and RHD in this setting 
was suboptimal, and many patients were using oral penicillin for 
secondary prophylaxis instead of the preferred parenteral form. 
These findings suggest that there is a need to raise awareness 
among patients, healthcare workers and policy makers on the 
importance of improving management of ARF and RHD patients, 
including best treatment practices to enable optimal utilisation of the 
available resources and consideration of establishing cardiac surgery 
programmes.
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